A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

November 30, 2022

Study Completion Date

January 30, 2023

Conditions
Respiratory Infections
Interventions
DEVICE

COVSurf Drug Delivery System

Device introduces surfactant to the patients lungs

OTHER

Standard of Care

Standard of care treatment for respiratory illness

Trial Locations (2)

SO16 6YD

University Hospital Southampton NHS Foundation Trust, Southampton

NW1 2BU

University College London Hospitals NHS Foundation Trust, London

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

University College, London

OTHER

lead

University Hospital Southampton NHS Foundation Trust

OTHER

NCT04362059 - A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19 | Biotech Hunter | Biotech Hunter